189 related articles for article (PubMed ID: 22749842)
21. Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity.
Gravius A; Laszy J; Pietraszek M; Sághy K; Nagel J; Chambon C; Wegener N; Valastro B; Danysz W; Gyertyán I
Behav Pharmacol; 2011 Apr; 22(2):122-35. PubMed ID: 21301322
[TBL] [Abstract][Full Text] [Related]
22. The Phosphodiesterase 10A Selective Inhibitor TAK-063 Improves Cognitive Functions Associated with Schizophrenia in Rodent Models.
Shiraishi E; Suzuki K; Harada A; Suzuki N; Kimura H
J Pharmacol Exp Ther; 2016 Mar; 356(3):587-95. PubMed ID: 26675680
[TBL] [Abstract][Full Text] [Related]
23. Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity.
Russo E; Citraro R; Davoli A; Gallelli L; Di Paola ED; De Sarro G
Neuropharmacology; 2013 Jan; 64():371-9. PubMed ID: 22766393
[TBL] [Abstract][Full Text] [Related]
24. A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease.
Harada K; Nakato K; Yarimizu J; Yamazaki M; Morita M; Takahashi S; Aota M; Saita K; Doihara H; Sato Y; Yamaji T; Ni K; Matsuoka N
Eur J Pharmacol; 2012 Jun; 685(1-3):59-69. PubMed ID: 22542656
[TBL] [Abstract][Full Text] [Related]
25. Antipsychotic drugs reverse MK-801-induced cognitive and social interaction deficits in zebrafish (Danio rerio).
Seibt KJ; Piato AL; da Luz Oliveira R; Capiotti KM; Vianna MR; Bonan CD
Behav Brain Res; 2011 Oct; 224(1):135-9. PubMed ID: 21669233
[TBL] [Abstract][Full Text] [Related]
26. The potential of nicotinic enhancement of cognitive remediation training in schizophrenia.
Hahn B; Gold JM; Buchanan RW
Neuropharmacology; 2013 Jan; 64():185-90. PubMed ID: 22705396
[TBL] [Abstract][Full Text] [Related]
27. FTBMT, a Novel and Selective GPR52 Agonist, Demonstrates Antipsychotic-Like and Procognitive Effects in Rodents, Revealing a Potential Therapeutic Agent for Schizophrenia.
Nishiyama K; Suzuki H; Harasawa T; Suzuki N; Kurimoto E; Kawai T; Maruyama M; Komatsu H; Sakuma K; Shimizu Y; Shimojo M
J Pharmacol Exp Ther; 2017 Nov; 363(2):253-264. PubMed ID: 28851764
[TBL] [Abstract][Full Text] [Related]
28. AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents.
Black MD; Stevens RJ; Rogacki N; Featherstone RE; Senyah Y; Giardino O; Borowsky B; Stemmelin J; Cohen C; Pichat P; Arad M; Barak S; De Levie A; Weiner I; Griebel G; Varty GB
Psychopharmacology (Berl); 2011 May; 215(1):149-63. PubMed ID: 21181124
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of modafinil on emotional memory in mice.
Fernandes HA; Zanin KA; Patti CL; Wuo-Silva R; Carvalho RC; Fernandes-Santos L; Bittencourt LR; Tufik S; Frussa-Filho R
Neuropharmacology; 2013 Jan; 64():365-70. PubMed ID: 22771974
[TBL] [Abstract][Full Text] [Related]
30. Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence-accelerated mouse model.
Dobarro M; Orejana L; Aguirre N; Ramírez MJ
Neuropharmacology; 2013 Jan; 64():137-44. PubMed ID: 22824191
[TBL] [Abstract][Full Text] [Related]
31. On the trail of a cognitive enhancer for the treatment of schizophrenia.
Stip E; Chouinard S; Boulay LJ
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):219-32. PubMed ID: 15694228
[TBL] [Abstract][Full Text] [Related]
32. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
33. Parametric and pharmacological modulations of latent inhibition in mouse inbred strains.
Lipina TV; Rasquinha R; Roder JC
Pharmacol Biochem Behav; 2011 Dec; 100(2):244-52. PubMed ID: 21903127
[TBL] [Abstract][Full Text] [Related]
34. A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.
Lee SW; Lee JG; Lee BJ; Kim YH
Int Clin Psychopharmacol; 2007 Mar; 22(2):63-8. PubMed ID: 17293705
[TBL] [Abstract][Full Text] [Related]
35. Treatment of cognitive dysfunction in schizophrenia.
Peuskens J; Demily C; Thibaut F
Clin Ther; 2005; 27 Suppl A():S25-37. PubMed ID: 16198199
[TBL] [Abstract][Full Text] [Related]
36. The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.
Weiner I
Psychopharmacology (Berl); 2003 Sep; 169(3-4):257-97. PubMed ID: 12601500
[TBL] [Abstract][Full Text] [Related]
37. Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD.
García-Barroso C; Ricobaraza A; Pascual-Lucas M; Unceta N; Rico AJ; Goicolea MA; Sallés J; Lanciego JL; Oyarzabal J; Franco R; Cuadrado-Tejedor M; García-Osta A
Neuropharmacology; 2013 Jan; 64():114-23. PubMed ID: 22776546
[TBL] [Abstract][Full Text] [Related]
38. Verbal memory.
Sumiyoshi T
Handb Exp Pharmacol; 2015; 228():237-47. PubMed ID: 25977085
[TBL] [Abstract][Full Text] [Related]
39. The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice.
Liddie S; Anderson KL; Paz A; Itzhak Y
J Psychopharmacol; 2012 Oct; 26(10):1375-82. PubMed ID: 22596207
[TBL] [Abstract][Full Text] [Related]
40. Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model.
Wang D; Noda Y; Zhou Y; Nitta A; Furukawa H; Nabeshima T
Neuropharmacology; 2007 Mar; 52(4):1179-87. PubMed ID: 17313962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
